Ashina, M
~ 200  Ergebnisse:
Personensuche X
?
1

P.005 Eptinezumab demonstrated efficacy regardless of prior..:

Pozo-Rosich, P ; Ashina, M ; Tepper, SJ...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  51 (2024)  s1 - p. S15-S15 , 2024
 
?
 
?
7

P.030 Long-term Safety and Tolerability of Atogepant 60 mg ..:

Ashina, M ; Tepper, SJ ; Reuter, U...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  48 (2021)  s3 - p. S28-S29 , 2021
 
?
9

P.566 Sumatriptan binds to central 5-HT1B receptors in migr..:

Deen, M. ; Hougaard, A. ; Hansen, H.D....
European Neuropsychopharmacology.  29 (2019)  - p. S398 , 2019
 
?
10

Reversion from chronic to episodic migraine and clinically ..:

Ashina, M. ; Ning, X. ; Galic, M....
Journal of the Neurological Sciences.  405 (2019)  - p. 45-46 , 2019
 
?
11

Odds ratios for response to fremanezumab in migraine patien..:

Diener, H.C. ; Ning, X. ; Galic, M....
Journal of the Neurological Sciences.  405 (2019)  - p. 64-65 , 2019
 
?
12

Reduction in migraine days with aura with fremanezumab in p..:

Ashina, M. ; Cohen, J.M. ; Yang, R....
Journal of the Neurological Sciences.  405 (2019)  - p. 43-44 , 2019
 
?
13

Intact blood−brain barrier during spontaneous attacks of mi..:

Amin, F. M. ; Hougaard, A. ; Cramer, S. P....
European Journal of Neurology.  24 (2017)  9 - p. 1116-1124 , 2017
 
?
14

No abnormalities of intrinsic brain connectivity in the int..:

Hougaard, A. ; Amin, F. M. ; Magon, S....
European Journal of Neurology.  22 (2015)  4 - p. 702 , 2015
 
1-15